Stem Cell Cartilage Regeneration Market Analysis | CMI

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
STEM CELL CARTILAGE REGENERATION MARKET ANALYSIS

• Stem Cell Cartilage Regeneration Market, by Stem
  Cell Type (Hematopoietic Stem Cells, Pluripotent
  Stem Cells, and Mesenchymal Stem Cells), by
  Treatment (Microfracture, Osteochondral
  Transplant, Autologous Chondrocyte Implantation,
  and Others), by End User (Hospitals Clinics and
  Ambulatory Surgical Centers), and By Region
  (North America, Latin America, Europe, Asia
  Pacific, Middle East, and Africa) - Size, Share,
  Outlook, and Opportunity Analysis, 2019 - 2027
• The global stem cell cartilage regeneration
  market is estimated to be valued at US 298.3
  million in 2019, and is expected to exhibit a
  CAGR of 9.1 over the forecast period
  (2020-2027).

3
Market Drivers

• Increasing adoption of minimally invasive surgery
  procedures is expected to drive growth of Stem
  Cell Cartilage Regeneration Market. Stem cell
  therapy for knees, minimally invasive procedure
  has the potential to decrease inflammation, halt
  progression of arthritic damage, repair joint
  cartilage, and delay or avoid knee replacement
  surgery. Injection of progenitor cells,
  especially mesenchymal stem cells (MSCs) is found
  to be an effective and better solution for
  repairing degenerative cartilage compared to
  implantation of differentiated cells such as
  articular cartilage.
• Increasing epidemic of osteoarthritis among the
  global population is expected to increase
  adoption of efficient and promising treatment
  such as stem cell therapy during the forecast
  period. For instance, according to the data
  findings published by Arthritis Foundation in
  November 2017, arthritis was the leading cause of
  disability among adults in the U.S. Over 53
  million adults worldwide suffered from arthritis,
  which refers to over 100 types of joint diseases.
  This is expected to increase 49 to reach over
  78.4 million by 2040.

4
Global Stem Cell Cartilage Regeneration Market
Share () Analysis, By Stem Cells, 2019
5
Stem Cell Cartilage Regeneration Market -
Regional Insights

• On the basis of region, the global stem cell
  cartilage regeneration market is segmented into
  North America, Latin America, Europe, Asia
  Pacific, Middle East, and Africa. North America
  is expected to be the most lucrative region for
  growth of the stem cell cartilage regeneration
  market over the forecast period, due to high
  presence of key players in the region. Key
  players such as Vericel Corporation, Osiris
  Therapeutics, among others are focusing on
  various growth strategies such as gaining
  regulatory product approvals and launching
  innovative stem cell-based cartilage regeneration
  products and technologies in the market.
• Furthermore, increasing geriatric population, who
  are more prone to degenerative disorders such as
  osteoarthritis among the U.S. population, is
  further expected to propel growth of the stem
  cell cartilage regeneration market in the region.
  For instance, according to the Centers for
  Disease Control and Prevention (CDC), July 2018
  data findings, from 2013-2015, around 54.4
  million U.S. adults (22.7 of total U.S.
  population) annually suffered from some form of
  arthritis such as rheumatoid arthritis, gout,
  lupus, or fibromyalgia.

6

• Asia Pacific stem cell cartilage regeneration
  market revenue is expected to witness significant
  growth over the forecast period. In India, stem
  cell-based cartilage regeneration procedures are
  conducted by various hospital and clinics.
  Moreover, hospitals such as Apollo, TOSH (Trauma
  Orthopaedic Speciality Hospital), among others
  are conducting stem cell-based knee arthritis
  surgery procedures.

7
Global Stem Cell Cartilage Regeneration Market,
Value (US Mn) Y-o-Y Growth (), 2016-2027
8
Global Stem Cell Cartilage Regeneration Market -
Competitive Landscape

• Major players operating in the global stem cell
  cartilage regeneration market include Theracell
  Advanced Biotechnology Ltd., Orthocell Ltd.,
  Xintela AB, CellGenix GmbH, Merck KGaA, Osiris
  Therapeutics, Inc., BioTissue SA, and Vericel
  Corporation.

9

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Reference https//www.coherentmarketinsights.com
  /market-insight/stem-cell-cartilage-regeneration-m
  arket-2448

10
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

11
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

12

• Thank You!
• Kindly follow CMI Social Media Profiles
  for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/